Filtered By:
Cancer: Cancer in Adolescents
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 137 results found since Jan 2013.
Human papillomavirus vaccination uptake among Native Hawaiian and Pacific Islander adults in the United States
CONCLUSIONS: The low HPV vaccination coverage found in this study signals the need for more evidence-based, culturally relevant immunization and cancer prevention interventions for NHPIs. Failure to improve HPV vaccination rates may increase the burden of HPV associated preventable cancers among NHPIs and broaden disparities.PMID:34563569 | DOI:10.1016/j.annepidem.2021.09.003
Source: Annals of Epidemiology - September 26, 2021 Category: Epidemiology Authors: Eric Adjei Boakye Tori Stierwalt Stacy Grundy Nosayaba Osazuwa-Peters Minjee Lee Meghan Elgee Mario Schootman Source Type: research
Risk-benefit analysis of 9-valent HPV vaccination for adolescent boys from an individual perspective
Jpn J Infect Dis. 2021 Jul 30. doi: 10.7883/yoken.JJID.2021.367. Online ahead of print.ABSTRACTJapan recently approved quadrivalent human papillomavirus (HPV) vaccine for males, but 9-valent vaccine is only approved for females. Given the low female vaccination rate due to a concern of adverse events in Japan, quantifying the risk and benefit of the HPV vaccination for male may help the decision making to vaccinate adolescent boys in Japan. Using quality-adjusted life years, the risk-benefit ratio for an adolescent boy to get the 9-valent HPV vaccination was calculated. The male HPV vaccination reduced the QALY gain due to...
Source: Japanese Journal of Infectious Diseases - August 2, 2021 Category: Infectious Diseases Authors: Taito Kitano Source Type: research
